Erratum to:Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid  

作　　者：Helin Wang Qi Lu Yifan Miao Jiaxuan Song Mingyang Zhang Haotian Zhang Zhonggui He Zixuan Wang Chutong Tian Jin Sun 

机构地区：[1]Department of Pharmaceutics,Wuya College of Innovation,Shenyang Pharmaceutical University,Shenyang 110016,China [2]School of Life Science and Biopharmaceutics,Shenyang Pharmaceutical University,Shenyang 110016,China

出　　处：《Nano Research》2023年第4期6010-6011,共2页纳米研究（英文版）

基　　金：Address correspondence to:Chutong Tian,[e-mail];Address correspondence to:Jin Sun,[e-mail]。

摘　　要：Erratum to Nano Research 2022,15(10):9092-9104 https://doi.org/10.1007/s12274-022-4544-7 Figure 9 was unfortunately mistakenly typeset.This error did not affect any of the conclusions from the published paper.

关 键 词：chemotherapy FIGURE COMBINE 

分 类 号：TB383-5[一般工业技术—材料科学与工程] G23[文化科学]